Key result
Coxsackievirus A24 variant engages sialylated O-linked glycans like PSGL-1 to infect ocular cells.
Sialylated O-linked glycoconjugates, particularly structures resembling PSGL-1 containing Neu5Acα2,3Gal, act as crucial cellular receptors for Coxsackievirus A24 variant entry into human ocular cells.
May guide entry inhibitor design for ocular viral disease; leaves clinical translation open pending in vivo studies.
Coxsackievirus A24 variant (CVA24v) is a main causative agent of acute hemorrhagic conjunctivitis (AHC), which is a highly contagious eye infection. Previously it has been suggested that CVA24v uses sialic acid-containing glycoconjugates as attachment receptors on corneal cells, but the nature of these receptors is poorly described. Here, we set out to characterize and identify the cellular components serving as receptors for CVA24v. Binding and infection experiments using corneal cells treated with deglycosylating enzymes or metabolic inhibitors of de novo glycosylation suggested that the receptor(s) used by CVA24v are constituted by sialylated O-linked glycans that are linked to one or more cell surface proteins but not to lipids. CVA24v bound better to mouse L929 cells overexpressing human P-selectin glycoprotein ligand-1 (PSGL-1) than to mock-transfected cells, suggesting that PSGL-1 is a candidate receptor for CVA24v. Finally, binding competition experiments using a library of mono- and oligosaccharides mimicking known PSGL-1 glycans suggested that CVA24v binds to Neu5Acα2,3Gal disaccharides (Neu5Ac is N-acetylneuraminic acid). These results provide further insights into the early steps of the CVA24v life cycle.
No takes yet. Share an insight, caveat, or question.
Mistry et al. (2011) studied Acute hemorrhagic conjunctivitis (Coxsackievirus A24 variant infection). Cellular surface glycosylation modification (e.g., PSGL-1 overexpression, glycosylation inhibitors) vs. Unmodified or untreated control cells was evaluated on Virus binding and infection of target cells. Coxsackievirus A24 variant binds and infects human ocular cells using sialylated O-linked glycoconjugates, particularly those containing Neu5Acα2,3Gal disaccharides such as PSGL-1.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: